🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Multiple sclerosis (MS) is the most common inflammatory demyelinating chron...
Status
Unknown
Location
University of Málaga
Start Date
2014-03
Trial ID
NCT02104492
Treatments Being Tested
PRACTICAL is a randomized multifactorial adaptive platform trial for acute ...
Status
Recruiting
Location
University of Arizona
Start Date
2023-04-30
Trial ID
NCT05440851
Treatments Being Tested
The proposed study is designed to answer a novel research question: Can res...
Status
Completed
Location
Frazier Rehabilitation and Neuroscience Institute
Start Date
2011-06
Trial ID
NCT02396823
Treatments Being Tested
* To determine effects of resistive expiratory muscle training on pulmonary...
Status
Completed
Location
Holy Family Hospital
Start Date
2021-10-10
Trial ID
NCT05061186
Treatments Being Tested
This study is a randomized trial examining the impact of expiratory muscle ...
Status
Recruiting
Location
University of Wisconsin Milwaukee
Start Date
2017-07-12
Trial ID
NCT03916809
Treatments Being Tested
When the soft palate does not move enough because of a cleft palate or for ...
Status
Recruiting
Location
UPMC Children's Hospital of Pittsburgh
Start Date
2025-03-03
Trial ID
NCT05492266
Treatments Being Tested
Multiple sclerosis (MS) is a primary disorder of the central nervous system...
Status
Completed
Location
Cleveland Clinic
Start Date
2012-09
Trial ID
NCT01758224
Treatments Being Tested
This study investigates whether respiratory muscle training (RMT) and dieta...
Status
Recruiting
Location
Embry-Riddle Aeronautical University
Start Date
2025-09-01
Trial ID
NCT07216755
Chronic obstructive pulmonary disease (COPD) is characterized by persistent...
Status
Recruiting
Location
Riphah International University
Start Date
2025-12-02
Trial ID
NCT07293429